文献速递神经头颈MR

重症肌无力眼外肌萎缩与脂肪替代的MRI证据

MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis.
PubMed 文献 · Neuroradiology · 2021-07-07

研究对19例伴慢性眼部症状或免疫治疗反应不佳的眼肌型或全身型重症肌无力患者及19名年龄匹配健康对照行眼眶MRI,由两名评估者独立判断眼外肌萎缩与脂肪替代并测量眼外肌最大厚度。患者组脂肪替代6/19(31.6%)vs 对照组0/19(0%)(p=0.02),至少一条肌肉明显萎缩8/19(42.1%)vs 1/19(5.3%)(p=0.019),平均总厚度及上直肌、提上睑肌、下直肌、上斜肌厚度两组差异有统计学意义。

要点

  • 眼肌型或全身型重症肌无力伴治疗困难者,MRI可见眼外肌萎缩和脂肪替代。
  • 患者组脂肪替代6/19(31.6%),对照组0/19(0%),p=0.02。
  • 至少一条眼外肌明显萎缩者患者组8/19(42.1%),对照组1/19(5.3%),p=0.019。

核心结论

  • 在该组伴治疗困难及眼部受累频繁复发的重症肌无力患者中,眼外肌萎缩和脂肪替代常见。

研究设计与样本

  • 19例眼肌型或全身型重症肌无力患者与19名年龄匹配健康对照行眼眶MRI,两名评估者独立评估肌肉萎缩和脂肪替代,并测量眼外肌最大厚度及计算总厚度。

关键影像表现/征象

  • 患者组MRI可见眼外肌脂肪替代和明显肌肉萎缩。
  • 患者组平均总厚度及上直肌、提上睑肌、下直肌、上斜肌厚度与对照组差异有统计学意义。

诊断标准与关键数值

  • 脂肪替代:患者组6/19(31.6%)vs 对照组0/19(0%),p=0.02。
  • 至少一条眼外肌明显萎缩:患者组8/19(42.1%)vs 对照组1/19(5.3%),p=0.019。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of the study was to evaluate extraocular muscle (EOM) atrophy and fatty replacement in ocular myasthenia gravis (OMG) and generalized myasthenia gravis (GMG) patients with chronic and untreated ocular symptoms or with inadequate response to immunotherapy and unprovoked ocular exacerbations despite chronic immunotherapy.

METHODS: Nineteen patients with either OMG or GMG and 19 healthy age-matched controls underwent an orbital MRI. Visually obvious muscle atrophy and muscle fatty replacement were evaluated by two raters independently. Maximum thickness of EOM was measured. Measurements of the muscles of each participant were added up, in order to calculate the total thickness.

RESULTS: Eleven patients suffered from AChR-positive GMG, and 8 patients from OMG. All patients had chronic ocular symptoms or inadequate response to corticosteroids and unprovoked ocular exacerbations in spite of immunotherapy. Fatty replacement was reported in 6/19 (31.6%) patients and 0/19 (0%) controls (p = 0.02). Obvious atrophy in at least one muscle was reported in 8/19 (42.1%) patients and 1/19 (5.3%) controls (p = 0.019). Statistically significant differences between the two groups were also found in the mean total thickness, as well as in the thickness of superior recti, levator palpebrae, inferior recti, and superior oblique muscles.

CONCLUSION: EOM atrophy and fatty replacement were seen frequently in our series of MG patients with treatment difficulties and frequent relapses of ocular involvement.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Velonakis G, Papadopoulos VE, Karavasilis E, et al. MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis. Neuroradiology. 2021. PMID: 34232334. doi:10.1007/s00234-021-02753-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。